InvestorsHub Logo
Followers 13
Posts 438
Boards Moderated 0
Alias Born 01/06/2015

Re: martind18 post# 16330

Friday, 12/04/2015 12:21:20 AM

Friday, December 04, 2015 12:21:20 AM

Post# of 32016
Afrezza had a year with no issues. It's the real deal.

Most large companies don't add a new medicine until it's been out a year.
That way any risk or side effects can be caught early.

The second year is when the growth happens
If everything the first year goes well.

Sanofi mentioned upfront the Afezza growth will be slow initially.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y